Results indicate a need for providers to ask depressed patients about their marijuana use.
A rise in overdose deaths is associated with overprescribing of opioid analgesic medications.
Fewer people believe marijuana is harmful.
Δ9-Tetrahydrocannabinol (THC) is the main psychoactive chemical ingredient in cannabis.
The report also sheds light on the most significant predictors of substance abuse.
The increased use of synthetic cannabinoids presents a serious public health threat.
Alterations in reward processing may increase users' risk of continued drug use and subsequent addiction.
Chronic and severe cannabis-dependence is associated with deficits in striatal dopamine release.
Marijuana use is associated with development of various neuropsychiatric conditions such as schizophrenia, anxiety, and depression.
Tetrahydrocannabinol (THC) is the main active chemical ingredient found in cannabis and is a potent cannabinoid receptor (CB)-1 agonist.
Prolonged cannabis use is a risk factor for periodontal disease.
Study links heavy cannabis use in male teens to increased mortality by age 60.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Lithium Monotherapy Effective in Treating Bipolar Disorder in Children
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Cognitive Behavioral Therapy May Alter Suicidal Ideation in Anxiety Disorders
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Cost-Effective Telehealth Alternatives for Veterans With Depression
- Polygenic Risk Scores Could Aid in Identifying Bipolar Disorder, Schizophrenia
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses